Mannkind (MNKD) Common Equity (2010 - 2026)
Mannkind's (MNKD) quarterly Common Equity came in at -$59.2 million in Q1 2026, down 0.98% year-on-year from -$59.8 million in Q1 2025, and down 16.02% on a QoQ basis from -$51.0 million in Q4 2025.
Mannkind (MNKD) Common Equity (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Common Equity data on file, last reported at -$59.2 million in Q1 2026.
- On a quarterly basis, Common Equity fell 0.98% year-over-year to -$59.2 million in Q1 2026; TTM through Mar 2026 was -$59.2 million, a 0.98% decrease from a year earlier, with the FY2025 full-year figure at -$51.0 million, up 35.26% from the prior year.
- Common Equity for Q1 2026 stood at -$59.2 million, down from -$51.0 million in the prior quarter.
- Over the last five years, Common Equity for MNKD reached as high as -$44.6 million in Q3 2025 and fell as low as -$260.5 million in Q2 2023.
- Historically, Common Equity has averaged -$176.1 million across 5 years, with a median of -$230.0 million in 2024.
- Across the five-year window, Common Equity tumbled 34.6% in 2022 and soared 78.78% in 2025, its largest moves.
- Year by year, Common Equity stood at -$250.5 million in 2022, then climbed by 1.74% to -$246.2 million in 2023, then soared by 67.98% to -$78.8 million in 2024, then surged by 35.26% to -$51.0 million in 2025, then retreated by 16.02% to -$59.2 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were -$59.2 million in Q1 2026, -$51.0 million in Q4 2025, and -$44.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -59.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.20 Mn |
| Dec 31, 2025 | -51.02 Mn |
| Sep 30, 2025 | -44.55 Mn |
| Jun 30, 2025 | -55.04 Mn |
| Mar 31, 2025 | -58.62 Mn |
| Dec 31, 2024 | -78.82 Mn |
| Sep 30, 2024 | -209.93 Mn |
| Jun 30, 2024 | -225.78 Mn |
| Mar 31, 2024 | -229.97 Mn |
| Dec 31, 2023 | -246.17 Mn |
| Sep 30, 2023 | -251.78 Mn |
| Jun 30, 2023 | -260.49 Mn |
| Mar 31, 2023 | -255.40 Mn |
| Dec 31, 2022 | -250.54 Mn |
| Sep 30, 2022 | -237.68 Mn |
| Jun 30, 2022 | -247.06 Mn |
| Mar 31, 2022 | -232.06 Mn |
| Dec 31, 2021 | -209.35 Mn |
| Sep 30, 2021 | -184.69 Mn |
| Jun 30, 2021 | -183.55 Mn |